The Sumatriptan Succinate Injection, cataloged under National Stock Number 6505-01-672-4394, is classified within Federal Supply Class 6505 (Drugs and Biologicals) of the Medical, Dental, and Veterinary Equipment group. The manufacturer of record is Glaxosmithkline, Llc. Government technical data includes 6 specifications, cited from the U.S. Government catalog. The record lists 2 manufacturer part numbers for this item, enabling identification through both NSN and commercial part number lookups. 2 additional reference documents (drawings, advisory and superseded references) are recorded in the U.S. Government catalog. Current acquisition status: Active. Unit of issue: KT.
| Parameter | Value |
|---|---|
| NSN | 6505-01-672-4394 |
| Primary Part Number | NDC00173-0479-00 |
| Item Name | Sumatriptan Succinate Injection |
| FSC / FSG | 6505 / 65 — Drugs and Biologicals |
| Manufacturer | Glaxosmithkline, Llc |
| Status | ACTIVE |
| Administration | SUBCUTANEOUS |
| Primary Container Content Quantity | 0.5 MILLILITERS |
| Primary Container Type | INJECTOR, AUTOMATIC |
| Protective Storage Feature | PROTECT FROM DIRECT SUNLIGHT |
| Pharmaceutical Vehicle Type | AQUEOUS |
| Active Medicament Medicinal Strength | 6.0 MILLIGRAMS SUMATRIPTAN SUCCINATE ACTIVE INGREDIENT |
| Acquisition Status | ACTIVE |
| DEMIL Code | DEMIL A — No Demilitarization Required |
| Hazard | Possible hazard — SDS may be required (DLA HMIC P) |
| Criticality Code | X |
| Unit of Issue | KT |
| Part Number | Manufacturer |
|---|---|
| NDC00173-0479-00 PRIMARY | Glaxosmithkline, Llc (USA) |
| NDC66993-0084-98 PRIMARY | Prasco, Llc (USA) |
| Reference | Meaning |
|---|---|
| 1510705 | 5/1 Secondary reference U.S. Government activity |
| 6505NCM184193 | 5/1 Secondary reference Defense Medical Standardization Board |
NSN 6505-01-672-4394 is a Sumatriptan Succinate Injection, manufactured by Glaxosmithkline, Llc, classified under FSC 6505, Drugs and Biologicals. Status: active.
NSN 6505-01-672-4394 has 2 manufacturer part numbers on file: NDC00173-0479-00 (Glaxosmithkline, Llc), NDC66993-0084-98 (Prasco, Llc).
Key specifications for NDC00173-0479-00: Administration: SUBCUTANEOUS; Primary Container Content Quantity: 0.5 MILLILITERS; Primary Container Type: INJECTOR, AUTOMATIC; Special Features: SUMATRIPTAN SUCCINATE 6MG INJECTION; 2 PREFILLED 0.5ML SYRINGE CARTRIDGES, EACH CONTAINING 6MG OF SUMATRIPTAN FOR SUBCUTANEOUS INJECTION. CARTON CONTAINING 6MG OF SUMATRIPTAN FOR SUBCUTANEOUS INJECTION. CARTON CONTAINS (1) SUMATRIPTAN AUTOINJECTOR PEN, (1) CARRYING CASE, INSTRUCTIONS FOR USE/INFORMATION FOR THE PATIENT, PRESCRIBING INFORMATION. STORE BETWEEN 2 AND 30 C (36 AND 86 F). PROTECT FROM LIGHT.. 6 specifications are documented in the U.S. Government catalog.
Possible hazard — SDS may be required (DLA HMIC P). Hazard information on this page is shown exactly as it appears in the DLA record.
U.S. Government catalog: edition PUBLOGDVD v12.0.0 (OCT 2026), edition date 2026-10-01, retrieved 2026-10-16.
U.S. Government catalog: edition PUBLOGDVD v12.0.0 (OCT 2026), edition date 2026-10-01, retrieved 2026-10-18.